Corindus Vascular Robotics, Inc.
closed
CVRS
Capital Structure & Economics
Trust SizeN/A
Unit Price$4.25
Warrant Coverage-
Sponsor Promote20%
Implied Equity Architecture
| Public Trust Allocation | N/A |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $4.25 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedAug 31, 2011
Target AnnouncedAug 7, 2019
Maturation Wall
Jan 1, 2019
Announced Target / M&A
- Target CompanySiemens Medical Solutions USA, Inc.
- Announcement Date2019-08-07
Board & Officers
- Mark J. TolandCEO
- David W. LongDirector
- Douglas TeanyDirector
- Jeffrey C. LightcapDirector
- Director
- Louis A. Cannon, M.D.Director
- Nathan R. HarringtonDirector
- James R. TobinDirector
- Campbell D. Rogers, M.D.Director
- Jeffrey G. GoldDirector
- David M. HandlerDirector
- Jeffrey LightcapDirector
- Hillel BachrachDirector
- Jeffrey GoldDirector
- David WhiteDirector
- Gerard WinkelsDirector
- Michael MashaalDirector
- Lisa GrossmanDirector
- Gabriel SolomonDirector
Syndicate & Advisors
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.